Priyank J. Shah

Array ( [id] => 4152994 [patent_doc_number] => 06103498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/840204 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 61 [patent_no_of_words] => 37643 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103498.pdf [firstpage_image] =>[orig_patent_app_number] => 840204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352190 [patent_doc_number] => 06218142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Nucleic acid molecules encoding polypeptides having the enzymatic activity of an RNA-directed RNA polymerase (RDRP)' [patent_app_type] => 1 [patent_app_number] => 8/811583 [patent_app_country] => US [patent_app_date] => 1997-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14369 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218142.pdf [firstpage_image] =>[orig_patent_app_number] => 811583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4231854 [patent_doc_number] => 06117664 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Alkaline cellulases' [patent_app_type] => 1 [patent_app_number] => 8/709974 [patent_app_country] => US [patent_app_date] => 1996-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18637 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117664.pdf [firstpage_image] =>[orig_patent_app_number] => 709974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500011 [patent_doc_number] => 06485960 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Polycystic kidney disease 1 gene and uses thereof' [patent_app_type] => B1 [patent_app_number] => 08/422582 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 104 [patent_no_of_words] => 60160 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485960.pdf [firstpage_image] =>[orig_patent_app_number] => 08422582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4308773 [patent_doc_number] => 06316226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Proteins with Factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them' [patent_app_type] => 1 [patent_app_number] => 8/416532 [patent_app_country] => US [patent_app_date] => 1995-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 10261 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316226.pdf [firstpage_image] =>[orig_patent_app_number] => 416532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550014 [patent_doc_number] => 06346513 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them' [patent_app_type] => B1 [patent_app_number] => 08/416535 [patent_app_country] => US [patent_app_date] => 1995-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 10178 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346513.pdf [firstpage_image] =>[orig_patent_app_number] => 08416535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494961 [patent_doc_number] => 06342583 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'cDNAs coding for members of the carcinoembryonic antigen family' [patent_app_type] => B1 [patent_app_number] => 08/027974 [patent_app_country] => US [patent_app_date] => 1993-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 12975 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342583.pdf [firstpage_image] =>[orig_patent_app_number] => 08027974 [rel_patent_id] =>[rel_patent_doc_number] =>)